158 related articles for article (PubMed ID: 24138636)
1. Hsp27 as a therapeutic target in cancers.
Acunzo J; Andrieu C; Baylot V; So A; Rocchi P
Curr Drug Targets; 2014 Apr; 15(4):423-31. PubMed ID: 24138636
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells.
Owen S; Zhao H; Dart A; Wang Y; Ruge F; Gao Y; Wei C; Wu Y; Jiang WG
Int J Oncol; 2016 Nov; 49(5):1839-1847. PubMed ID: 27600495
[TBL] [Abstract][Full Text] [Related]
3. Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
Choi SK; Kam H; Kim KY; Park SI; Lee YS
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31426426
[TBL] [Abstract][Full Text] [Related]
4. Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
Musiani D; Konda JD; Pavan S; Torchiaro E; Sassi F; Noghero A; Erriquez J; Perera T; Olivero M; Di Renzo MF
FASEB J; 2014 Sep; 28(9):4055-67. PubMed ID: 24903273
[TBL] [Abstract][Full Text] [Related]
5. Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF.
Konda JD; Olivero M; Musiani D; Lamba S; Di Renzo MF
Mol Oncol; 2017 Jun; 11(6):599-611. PubMed ID: 28182330
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery Approaches.
Umar HI; Ajayi AT; Mukerjee N; Aborode AT; Hasan MM; Maitra S; Bello RO; Alabere HO; Sanusi AA; Awolaja OO; Alshehri MM; Chukwuemeka PO; Aljarba NH; Alkahtani S; Malik S; Alexiou A; Ghosh A; Rahman MH
Cells; 2022 Aug; 11(15):. PubMed ID: 35954254
[TBL] [Abstract][Full Text] [Related]
7. The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer.
Liu CL; Chen SF; Wu MZ; Jao SW; Lin YS; Yang CY; Lee TY; Wen LW; Lan GL; Nieh S
Oncotarget; 2016 Mar; 7(12):14279-90. PubMed ID: 26872057
[TBL] [Abstract][Full Text] [Related]
8. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
Díaz-Chávez J; Fonseca-Sánchez MA; Arechaga-Ocampo E; Flores-Pérez A; Palacios-Rodríguez Y; Domínguez-Gómez G; Marchat LA; Fuentes-Mera L; Mendoza-Hernández G; Gariglio P; López-Camarillo C
PLoS One; 2013; 8(5):e64378. PubMed ID: 23724044
[TBL] [Abstract][Full Text] [Related]
9. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).
Wang X; Chen M; Zhou J; Zhang X
Int J Oncol; 2014 Jul; 45(1):18-30. PubMed ID: 24789222
[TBL] [Abstract][Full Text] [Related]
10. HSP27-Mediated Extracellular and Intracellular Signaling Pathways Synergistically Confer Chemoresistance in Squamous Cell Carcinoma of Tongue.
Zheng G; Zhang Z; Liu H; Xiong Y; Luo L; Jia X; Peng C; Zhang Q; Li N; Gu Y; Lu M; Song Y; Pan H; Liu J; Liu W; He Z
Clin Cancer Res; 2018 Mar; 24(5):1163-1175. PubMed ID: 29246940
[No Abstract] [Full Text] [Related]
11. HspB1 dynamic phospho-oligomeric structure dependent interactome as cancer therapeutic target.
Arrigo AP; Gibert B
Curr Mol Med; 2012 Nov; 12(9):1151-63. PubMed ID: 22804238
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of heat shock protein 27 confers resistance to actinomycin D-induced apoptosis in cancer cells.
Ma W; Teng Y; Hua H; Hou J; Luo T; Jiang Y
FEBS J; 2013 Sep; 280(18):4612-24. PubMed ID: 23848600
[TBL] [Abstract][Full Text] [Related]
14. HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
Pavan S; Musiani D; Torchiaro E; Migliardi G; Gai M; Di Cunto F; Erriquez J; Olivero M; Di Renzo MF
Int J Cancer; 2014 Mar; 134(6):1289-99. PubMed ID: 23996744
[TBL] [Abstract][Full Text] [Related]
15. New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells.
Heinrich JC; Donakonda S; Haupt VJ; Lennig P; Zhang Y; Schroeder M
Oncotarget; 2016 Oct; 7(42):68156-68169. PubMed ID: 27626687
[TBL] [Abstract][Full Text] [Related]
16. Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27.
Hsu HS; Lin JH; Huang WC; Hsu TW; Su K; Chiou SH; Tsai YT; Hung SC
Cancer; 2011 Apr; 117(7):1516-28. PubMed ID: 21425153
[TBL] [Abstract][Full Text] [Related]
17. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 27 influences the anti-cancer effect of curcumin in colon cancer cells through ROS production and autophagy activation.
Liang HH; Huang CY; Chou CW; Makondi PT; Huang MT; Wei PL; Chang YJ
Life Sci; 2018 Sep; 209():43-51. PubMed ID: 30056019
[TBL] [Abstract][Full Text] [Related]
19. The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.
Katsogiannou M; Andrieu C; Baylot V; Baudot A; Dusetti NJ; Gayet O; Finetti P; Garrido C; Birnbaum D; Bertucci F; Brun C; Rocchi P
Mol Cell Proteomics; 2014 Dec; 13(12):3585-601. PubMed ID: 25277244
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-mediated silencing of heat shock protein 27 (HSP27) Increases chemosensitivity to paclitaxel by increasing production of reactive oxygen species in human ovarian cancer cells (HO8910).
Song TF; Zhang ZF; Liu L; Yang T; Jiang J; Li P
J Int Med Res; 2009; 37(5):1375-88. PubMed ID: 19930842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
